Targeting tyrosine-kinases and estrogen receptor abrogates resistance to endocrine therapy in breast cancer-Reference-Cited by-同舟云学术

Targeting tyrosine-kinases and estrogen receptor abrogates resistance to endocrine therapy in breast cancer

Published:2014-05-27 Issue:19 Volume:5 Page:9049-9064
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Liu Shuying¹,Meng Xiaolong¹,Chen Huiqin¹,Liu Wenbin²,Miller Todd³⁴,Murph Mandi⁵,Lu Yiling⁶,Zhang Fan⁶,Gagea Mihai⁷,Arteaga Carlos L.⁴⁸⁹,Mills Gordon B.⁶,Meric-Bernstam Funda¹⁰,González-Angulo Ana M.¹⁶

Affiliation:

1. Department of Breast Medical Oncology, The University of Texas, MD Anderson Cancer Center, Houston, TX

2. Department of Bioinformatics and Computational Biology, The University of Texas, MD Anderson Cancer Center, Houston, TX

3. Department of Pharmacology & Toxicology, Norris Cotton Cancer Center, Geisel School of Medicine at Dartmouth, Lebanon, NH

4. Department of Cancer Biology, Vanderbilt-Ingram Cancer Center, Vanderbilt University, Nashville, TN

5. University of Georgia College of Pharmacy, Athens, GA

6. Department of Systems Biology, The University of Texas, MD Anderson Cancer Center, Houston, TX

7. Department of Veterinary Medicine and Surgery, The University of Texas, MD Anderson Cancer Center, Houston, TX

8. Breast Cancer Research Program, Vanderbilt-Ingram Cancer Center, Vanderbilt University, Nashville, TN

9. Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University, Nashville, TN

10. Department of Surgical Oncology, The University of Texas, MD Anderson Cancer Center, Houston, TX

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Growth Factor Receptor Implications in Breast Cancer: Prospects for Their Molecular Transactivation in the Future and Obstacles for Target Therapy;Interdisciplinary Cancer Research;2024

2. PDK4 promotes tumorigenesis and cisplatin resistance in lung adenocarcinoma via transcriptional regulation of EPAS1;Cancer Chemotherapy and Pharmacology;2020-11-21

3. How Different Are the Molecular Mechanisms of Nodal and Distant Metastasis in Luminal A Breast Cancer?;Cancers;2020-09-16

4. Tamoxifen and the PI3K Inhibitor: LY294002 Synergistically Induce Apoptosis and Cell Cycle Arrest in Breast Cancer MCF-7 Cells;Molecules;2020-07-24

5. Reprogramming of Amino Acid Transporters to Support Aspartate and Glutamate Dependency Sustains Endocrine Resistance in Breast Cancer;Cell Reports;2019-07